NGOs call upon Indian govt to reject US pressure on economic policies ... pharmabiz.com The NGOs in its open letter said that through CLs India could allow generic production of medicine 'sorafenib tosylate' to treat kidney and liver cancer patients at the cost of Rs. 8,800 per month (approximately US$175), while the same patented ... |
